Multidrug-resistant Commensal<i>Escherichia coli</i>in Children, Peru and Bolivia

dc.contributor.authorAlessandro Bartoloni
dc.contributor.authorLucia Pallecchi
dc.contributor.authorMarta Benedetti
dc.contributor.authorConnie Fernandez
dc.contributor.authorYolanda Vallejos
dc.contributor.authorElisa Guzmán
dc.contributor.authorAna Liz Villagrán
dc.contributor.authorAntonia Mantella
dc.contributor.authorChiara Lucchetti
dc.contributor.authorFilippo Bartalesi
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:01:48Z
dc.date.available2026-03-22T14:01:48Z
dc.date.issued2006
dc.descriptionCitaciones: 115
dc.description.abstractUsing a rapid screening method, we investigated the prevalence of fecal carriage of antimicrobial drug-resistant Escherichia coli in 3,174 healthy children from 4 urban settings in Peru and Bolivia. High resistance rates were observed for ampicillin (95%), trimethoprim-sulfamethoxazole (94%), tetracycline (93%), streptomycin (82%), and chloramphenicol (70%). Lower resistance rates were observed for nalidixic acid (35%), kanamycin (28%), gentamicin (21%), and ciprofloxacin (18%); resistance to ceftriaxone and amikacin was uncommon (<0.5%). In a random sample of 1,080 resistant E. coli isolates, 90% exhibited a multidrug-resistance (MDR) phenotype. The 2 most common MDR phenotypes (ampicillin/tetracycline/trimethoprim-sulfamethoxazole and ampicillin/tetracycline/trimethoprim-sulfamethoxazole/chloramphenicol) could be transferred en bloc in conjugation experiments. The most common acquired resistance genes were blaTEM, tet(A), tet(B), drfA8, sul1, sul2, and catI. These findings underscore the magnitude of the problem of antimicrobial drug resistance in low-resource settings and the urgent need for surveillance and control of this phenomenon.
dc.identifier.doi10.3201/eid1206.051258
dc.identifier.urihttps://doi.org/10.3201/eid1206.051258
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44126
dc.language.isoen
dc.publisherCenters for Disease Control and Prevention
dc.relation.ispartofEmerging infectious diseases
dc.sourceUniversity of Florence
dc.subjectEscherichia coli
dc.subjectMultiple drug resistance
dc.subjectMicrobiology
dc.subjectEscherichia coli Proteins
dc.subjectBiology
dc.subjectVirology
dc.subjectAntibiotic resistance
dc.subjectDrug resistance
dc.titleMultidrug-resistant Commensal<i>Escherichia coli</i>in Children, Peru and Bolivia
dc.typearticle

Files